E2F1 and neoplasm: Specifically, low expression of ARRB1 promotes tumor growth enhancing the E2F1 survival function, while high expression of ARRB1 triggers E2F1 acetylation switching E2F1 function from pro-survival into pro-apoptotic (Miele et al., 2021).